英文名稱 | Vedolizumab |
---|---|
中文名稱 | 維多珠單抗 |
CAS號(hào) | 943609-66-3 |
外觀 | Colorless to light yellow (Solution) |
儲(chǔ)存條件 | Sealed and Store at -80°C. Aliquots should be stored at the same temperature after first use to avoid freeze-thaw cycles |
規(guī)格 | 庫(kù)存 | 目錄價(jià) | 會(huì)員專享價(jià) | 數(shù)量 |
---|---|---|---|---|
1 mg | 3-5days | ¥3000.00 | 登錄后可見(jiàn) | |
5 mg | 3-5days | ¥12500.00 | 登錄后可見(jiàn) | |
10 mg | 3-5days | ¥20000.00 | 登錄后可見(jiàn) | |
50 mg | 3-5days | ¥80000.00 | 登錄后可見(jiàn) | |
100 mg | 3-5days | ¥125000.00 | 登錄后可見(jiàn) |
英文名稱 | Vedolizumab |
---|---|
中文名稱 | 維多珠單抗 |
CAS號(hào) | 943609-66-3 |
外觀 | Colorless to light yellow (Solution) |
儲(chǔ)存條件 | Sealed and Store at -80°C. Aliquots should be stored at the same temperature after first use to avoid freeze-thaw cycles |
Vedolizumab (anti-α4β7-integrin) is a humanized IgG1 monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease.